Biogen, Inc. (BIIB)

164.42 -4.15 (-2.46%) USD  |  NASDAQ  |  Jan 16, 16:00
167.60 +3.18 (+1.93%) After-Hours: 20:00
More

Biogen Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
AbbVie, Inc. Upgrade
Stoke Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Insmed, Inc. Upgrade